Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This trial involves 4 intervention regions with different palliative care system development across Japan: Chiba (Kashiwa city), Shizuoka (Hamamatsu city), Nagasaki (Nagasaki city), and Yamagata (Tsuruoka, Mikawa-cho; Figure 1). Chiba, Shizuoka, and Nagasaki have a growing organized system to provide palliative care led by a national cancer center, a general hospital, and a regional general practitioner association, respectively. Yamagata has an unorganized system of palliative care. The study subjects are all residents of the participating regions, including the general public, patients, their families, and health care providers.
Exclusion criteria
Exclusion criteria: The residents who disagree with the participation of this study are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)patient-reported quality of palliative care 2)bereaved family-reported quality of palliative care 3)number of patients who received specialized palliative care services 4)place of death distribution The quality of palliative care is measured by the Care Evaluation Scale, a validated tool to quantify user-perceived quality of care | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)knowledge, competency, and difficulties of regional physicians and nurses 2)quality indicators of regional palliative care, including opioid consumption and the number of nursing agencies providing around-the clock services. | — |
Countries
Japan
Contacts
Teikyo University School of Medicine Department of Internal Medicine